Real‐world performance of the <scp>MiniMed 780G</scp> advanced hybrid closed loop system in Latin America: Substantial improvement in glycaemic control with each technology iteration of the <scp>MiniMed</scp> automated insulin delivery system

Abstract

Real-world Latin American MM780G users on average showed good glucose control, achieving international targets. Glycaemic control increased with every technology iteration of the MM system, providing more automation each time.